On the basis of these studies, food intake impacts the pharmacokinetics of semaglutide and it is necessary to advise patients to fast before administration of the drug [28]
Casi la mitad de los pacientes experimentan efectos gastrointestinales nuseas, vmitos, diarrea que en general desaparecen al cabo de unos das, pero en algunos casos persisten y provocan el abandono del tratamiento
Ozempic is FDA-approved for type 2 diabetes management, while Wegovy is FDA-approved for chronic weight management in adults with obesity or overweight
GLP-1 medications like semaglutide primarily cause digestive issues as your body adjusts to slower stomach emptying
During the adjustment period, joints may feel off, even without an injury
1 GLP-1 receptor agonists are a class of medications that mimic and amplify these effects